This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Medintech Inc.. Active years: 2025.
Company Filing History:
Years Active: 2025
Title: Seokho Cho - Innovator in Endoscopic Imaging Technology
Introduction
Seokho Cho is a prominent inventor based in Seoul, South Korea. He has made significant contributions to the field of medical imaging, particularly in the detection of lesions through endoscopic images. His innovative approach combines artificial intelligence with medical technology, showcasing the potential of modern computing in healthcare.
Latest Patents
Seokho Cho holds a patent for a "Method of detecting lesions in endoscopic images, and method and computing device for training artificial neural network model that performs the same." This patent outlines a method for training an artificial neural network model to detect lesions in endoscopic images. The process involves generating training data that includes labels for lesions based on the characteristics of the endoscopic images and the lesions themselves. This advancement is crucial for improving diagnostic accuracy in medical settings.
Career Highlights
Seokho Cho is associated with Medintech Inc., a company that focuses on innovative medical technologies. His work at Medintech has allowed him to apply his expertise in artificial intelligence to real-world medical challenges. With a patent portfolio that includes 1 patent, he is recognized for his contributions to enhancing endoscopic imaging techniques.
Collaborations
Seokho Cho collaborates with talented individuals in his field, including Myungjoon Kim and Donghyeok Kim. These partnerships foster a creative environment that drives innovation and leads to the development of cutting-edge medical technologies.
Conclusion
Seokho Cho's work exemplifies the intersection of technology and healthcare, particularly in the realm of endoscopic imaging. His innovative methods and collaborations are paving the way for advancements that can significantly improve patient outcomes.